Analyst firms · Barclays · DHR
Barclays DHR price target and rating history
Danaher Corporation (DHR) · Industrials
Barclays rates Danaher Corporation (DHR) Overweight with a $205 price target, as of its latest action on Apr 10, 2025. It has published 6 rating actions on DHR since July 2021, including 1 upgrade and 1 downgrade. Across 7 firms with a DHR price target in the last 12 months, the median target is $230.
- Current rating
- Overweight
- Price target
- $205
- Median target, all firms
- $230
- Actions on DHR
- 6
Barclays price target on DHR
Every Barclays rating on DHR
- Apr 10, 2025
- Jan 24, 2024
- Jan 27, 2022
- Oct 22, 2021
- Jul 23, 2021
- Jul 13, 2021
How other firms rate DHR
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Buy | $250 | Sep 9, 2026 |
| Piper Sandler | Neutral | $200 | Jun 11, 2026 |
| DZ Bank | Buy | $210 | Jun 3, 2026 |
| Wolfe Research | Peer Perform | Jun 2, 2026 | |
| Citigroup | Buy | $230 | May 26, 2026 |
| RBC Capital Markets | Outperform | $200 | May 15, 2026 |
| Goldman Sachs | Buy | $265 | Dec 9, 2025 |
| Morgan Stanley | Overweight | $270 | Dec 2, 2025 |
Questions about Barclays and DHR
- What is Barclays's price target for DHR?
- Barclays's latest stated price target for Danaher Corporation (DHR) is $205, from its action on Apr 10, 2025.
- What is Barclays's rating on DHR?
- Barclays rates DHR Overweight, a bullish rating, as of Apr 10, 2025.
- When did Barclays last change its view on DHR?
- On Apr 10, 2025, Barclays upgrades to Overweight from Equal Weight, price target $205.
- How does Barclays's DHR target compare with other analysts?
- Across 7 firms with a DHR price target in the last 12 months, the median target is $230.
More DHR rating histories
- Wolfe Research3
- RBC Capital Markets5
- Goldman Sachs4
- BofA Securities3
- Wells Fargo5
- Credit Suisse4
- The Benchmark Company3
All Barclays ratingsDHR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.